Search
Search Results
- Publication:
- Washington, DC : United States Government Accountability Office, October 2017
- Subject(s):
- Analgesics, Opioid -- therapeutic use
Drug Utilization Review
Government Regulation
Inappropriate Prescribing
Medicare Part D
Prescription Drug Misuse
Fraud -- prevention & control
Opioid-Related Disorders
Humans
United States
Centers for Medicare & Medicaid Services (U.S.)
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, February 2021
- Subject(s):
- Analgesics, Opioid
COVID-19
Government Regulation
Medicare Part D
United States
United States. Department of Health and Human Services
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, September 2022
- Subject(s):
- Government Regulation
Medicare Part D
Opiate Overdose
Opioid-Related Disorders
United States
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, June 2022
- Subject(s):
- Dual MEDICAID MEDICARE Eligibility
Government Regulation
Medicare Part D
Prescription Drugs
United States
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, May 2023
- Subject(s):
- Buprenorphine
Buprenorphine, Naloxone Drug Combination
Government Regulation
Medicare Part D
Opioid-Related Disorders -- drug therapy
United States
- Publication:
- Washington, D.C. : U.S. Department of Health and Human Services, Office of Inspector General, July 2023
- Subject(s):
- Dual MEDICAID MEDICARE Eligibility
Formularies as Topic
Government Regulation
Medicare Part D
Prescription Drugs
United States
